Skip to nav Skip to content
Anna  Coghill

Anna Coghill, PhD, MPH

Program: Cancer Epidemiology

Research Program: Cancer Epidemiology Program

Google Scholar Profile


  • Overview

    Antiretroviral therapy has proven to be remarkably effective at improving overall survival in people living with HIV (PLWH). One unintended correlate of this longevity is a growing burden of chronic diseases  such as cancer in patients with HIV. In fact, cancer is now the second leading cause of death in PLWH. My research program focuses on the intersection between HIV and cancer, including projects to identify immunological and healthcare-associated factors in PLWH that may be associated with clinical outcomes in these patients.    


    • Cancer Epidemiology
    • Gastrointestinal Oncology
    • Cancer Epidemiology Program
    • Center for Immunization & Infection Research in Cancer

    Education & Training


    • University of Washington, PhD - Epidemiology
    • Emory University, MPH - Global Health


    • NIH/National Cancer Institute - Infections/Immunoepidemiology
  • Research Interest

    Anna E. Coghill, PhD, MPH is an Assistant Member in the Cancer Epidemiology Program at the H. Lee Moffitt Cancer Center & Research Institute.  Her interest in the intersection between infectious agents and cancer began during her dissertation work focusing on HIV as a determinant of cancer patient survival at the UCI/Hutchinson Cancer Center Alliance in Uganda.  This work suggested that HIV was not only related to cancer development but that it also played a role in how patients survived after a cancer diagnosis.  Dr. Coghill’s publications using the HIV/AIDS Cancer Match Study and National Cancer Database, as well as collaborations with the Brazilian National Cancer Institute, have established that HIV-infected cancer patients experience worse stage-specific survival that their HIV-uninfected counterparts. Her research program is now focused on identifying both healthcare-related and molecular reasons for this survival disparity, and she serves as the Moffitt Site Principal Investigator for the AIDS Malignancy Consortium, an NCI-funded clinical trials network to support innovative cancer prevention and treatment trials for PLWH and cancer.   

  • Participating Trials

    Clinical Trial 21261
    Characterizing the Gut Microbiome in Cancer Patients with Underlying HIV Infection
    Condition: Gastrointestinal Tumor
    Status: Open

    Clinical Trial 22531
    Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium
    Condition: Multiple
    Status: Open

    Clinical Trial 23143
    Trends and Outcomes in HIV-positive Patients Undergoing Treatment for Invasive or Preinvasive Cervical and Other Gynecologic Neoplasias
    Condition: Gynecological Tumor
    Status: Open

    If you believe you are eligible for one of these trials or studies, please call
    813-745-6100 or toll-free 1-800-679-0775.

  • Publications

    • Dickey BL, Yanik EL, Thompson Z, Burkholder G, Kitahata MM, Moore RD, Jacobson J, Mathews WC, Christopoulos KA, Fleming J, Napravnik S, Achenbach C, Coghill AE. The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2024 Mar.95(3):275-282. Pubmedid: 37977197.
    • Suk-Ouichai C, Coghill AE, Schabath MB, Sanchez JA, Chahoud J, Necchi A, Giuliano AR, Spiess PE. A clinical overview of people living with HIV and genitourinary cancer care. Nat Rev Urol. 2024 Jun.21(6):373-383. Pubmedid: 38238527.
    • Engels EA, Shiels MS, Barnabas RV, Bohlius J, Brennan P, Castilho J, Chanock SJ, Clarke MA, Coghill AE, Combes JD, Dryden-Peterson S, D'Souza G, Gopal S, Jaquet A, Lurain K, Makinson A, Martin J, Muchengeti M, Newton R, Okuku F, Orem J, Palefsky JM, Ramaswami R, Robbins HA, Sigel K, Silver S, Suneja G, Yarchoan R, Clifford GM. State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 2024 Feb.154(4):596-606. Pubmedid: 37715370.
    • Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, Putney RM, Mesa TE, Yoder SJ, Suneja G, Spivak AM, Patel AB, Extermann M, Giuliano AR, Teng M, Kresovich J, Berglund A, Coghill AE. Clonal hematopoiesis in patients with HIV and cancer. J Infect Dis. 2024 Apr. Pubmedid: 38657098.
    • Dube Mandishora RS, Galati L, Reich RR, Combes JD, McKay-Chopin S, Makunike-Mutasa R, Masanganise R, Gwambiwa B, Magombei T, Zito FA, Lagiou P, Clifford GM, Giuliano AR, Coghill AE, Tommasino M, Gheit T. Epstein-Barr Virus DNA Is Associated With Conjunctival Squamous Cell Carcinomas: A Case-Control Study From Zimbabwe. Open Forum Infect Dis. 2024 Apr.11(4):ofae165. Pubmedid: 38623569. Pmcid: PMC11017324.
    • Khouri A, Islam JY, Van Bibber NW, Coghill AE, Suneja G. Cancer treatment delays among cancer patients living with HIV during the COVID-19 pandemic in the United States. Cancer Med. 2023 Sep.12(18):18717-18728. Pubmedid: 37712718. Pmcid: PMC10557907.
    • Dickey BL, Putney RM, Suneja G, Kresovich JK, Spivak AM, Patel AB, Teng M, Extermann M, Giuliano AR, Gillis N, Berglund A, Coghill AE. Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer. Aids. 2023 Nov.37(13):2049-2057. Pubmedid: 37467055. Pmcid: PMC10538418.
    • Argirion I, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Middeldorp JM, Sarathkumara YD, Hsu WL, Chien YC, Lou PJ, Wang CP, Rothman N, Lan Q, Chen CJ, Mbulaiteye SM, Jarrett RF, Glimelius I, Smedby KE, Hjalgrim H, Hildesheim A, Doolan DL, Liu Z. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies. Cancer Epidemiol Biomarkers Prev. 2023 May.32(5):687-696. Pubmedid: 36788424. Pmcid: PMC10159936.
    • Dickey BL, Giuliano AR, Sirak B, Abrahamsen M, Lazcano-Ponce E, Villa LL, Coghill AE. Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study. J Infect Dis. 2023 Jan.227(2):256-260. Pubmedid: 35679351. Pmcid: PMC10202421.
    • Coghill A, Sanchez J, Sinha S, Permuth JB, Laskowitz D, Powers BD, Dineen SP. Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection. Cancer Rep (Hoboken). 2022 Oct.5(10):e1667. Pubmedid: 35869601. Pmcid: PMC9575487.
    • Islam JY, Nogueira L, Suneja G, Coghill A, Akinyemiju T. Palliative Care Use Among People Living With HIV and Cancer: An Analysis of the National Cancer Database (2004-2018). JCO Oncol Pract. 2022 Oct.18(10):e1683-e1693. Pubmedid: 35867956. Pmcid: PMC9663140.
    • Coghill AE, Brownstein NC, Sinha S, Thompson ZJ, Dickey BL, Hoogland AI, Johnstone PA, Suneja G, Jim HS. Patient-Reported Outcomes in Cancer Patients with HIV. Cancers (Basel). 2022 Nov.14(23). Pubmedid: 36497369. Pmcid: PMC9739107.
    • Ibrahim Khalil A, Mpunga T, Wei F, Baussano I, de Martel C, Bray F, Stelzle D, Dryden-Peterson S, Jaquet A, Horner MJ, Awolude OA, Trejo MJ, Mudini W, Soliman AS, Sengayi-Muchengeti M, Coghill AE, van Aardt MC, De Vuyst H, Hawes SE, Broutet N, Dalal S, Clifford GM. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. Int J Cancer. 2022 Mar.150(5):761-772. Pubmedid: 34626498. Pmcid: PMC8732304.
    • Sinha S, Dickey BL, Coghill AE. Utility of Epstein-Barr virus (EBV) antibodies as screening markers for nasopharyngeal carcinoma: a narrative review. Ann Nasopharynx Cancer. 2022 Jun.6. Pubmedid: 35996401. Pmcid: PMC9392954.
    • Coghill AE, Dickey BL. Room to Grow: The Need for Cancer Site-Specific Research Into Biomarkers of Aging and Immunity in People With HIV. J Natl Cancer Inst. 2022 Jun.114(6):790-791. Pubmedid: 35292810. Pmcid: PMC9194629.
    • Coghill AE, Kim Y, Hodge JM, Bender N, Smith-Warner SA, Teras LR, Grimsrud TK, Waterboer T, Egan KM. Prospective investigation of herpesvirus infection and risk of glioma. Int J Cancer. 2022 Jul.151(2):222-228. Pubmedid: 35225352.
    • Chen GH, Liu Z, Yu KJ, Coghill AE, Chen XX, Xie SH, Lin DF, Huang QH, Lu YQ, Ling W, Lin CY, Lu ZJ, Fan YY, Tang LQ, Sampson JN, Li H, King AD, Middeldorp JM, Hildesheim A, Cao SM. Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs. Clin Chem. 2022 Jul.68(7):953-962. Pubmedid: 35325087.
    • Coghill AE, Fang J, Liu Z, Chen CJ, Jarrett RF, Hjalgrim H, Proietti C, Yu KJ, Hsu WL, Lou PJ, Wang CP, Zhao Y, Doolan DL, Hildesheim A. Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response. Int J Infect Dis. 2022 Jan.114:65-71. Pubmedid: 34728343. Pmcid: PMC8724419.
    • Coghill AE, McGuire A, Sinha S, Homad L, Sinha I, Sholukh A, Koh WP, Yuan JM. Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma. Open Forum Infect Dis. 2022 Dec.9(12):ofac635. Pubmedid: 36519117. Pmcid: PMC9745775.
    • Dickey BL, Coghill AE, Rathwell JA, Reich RR, Vadaparampil ST, Christy SM, Roetzheim R, Shenkman E, Giuliano AR. Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018. Prev Med. 2022 Aug.161:107136. Pubmedid: 35803347. Pmcid: PMC9598903.
    • Liu Z, Li H, Yu KJ, Xie SH, King AD, Ai QH, Chen WJ, Chen XX, Lu ZJ, Tang LQ, Wang L, Xie CM, Ling W, Lu YQ, Huang QH, Coghill AE, Fakhry C, Pfeiffer RM, Zeng YX, Cao SM, Hildesheim A. Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma. Cancer. 2021 Sep.127(18):3403-3412. Pubmedid: 34231883.
    • Creed JH, Wilson CM, Soupir AC, Colin-Leitzinger CM, Kimmel GJ, Ospina OE, Chakiryan NH, Markowitz J, Peres LC, Coghill A, Fridley BL. spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data. Bioinformatics. 2021 Nov. Pubmedid: 34734969. Pmcid: PMC8652029.
    • Egan KM, Kim Y, Bender N, Hodge JM, Coghill AE, Smith-Warner SA, Rollison DE, Teras LR, Grimsrud TK, Waterboer T. Prospective investigation of polyomavirus infection and the risk of adult glioma. Sci Rep. 2021 May.11(1):9642. Pubmedid: 33953301. Pmcid: PMC8100283.
    • Chiao EY, Coghill A, Kizub D, Fink V, Ndlovu N, Mazul A, Sigel K. The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol. 2021 Jun.22(6):e240-e253. Pubmedid: 34087151. Pmcid: PMC8628366.
    • Hodge JM, Coghill AE, Kim Y, Bender N, Smith-Warner SA, Gapstur S, Teras LR, Grimsrud TK, Waterboer T, Egan KM. Toxoplasma gondii infection and the risk of adult glioma in two prospective studies. Int J Cancer. 2021 Jan. Pubmedid: 33427315.
    • Lee MH, Huang YH, Coghill AE, Liu Z, Yu KJ, Hsu WL, Chien YC, Wang CP, Chen TC, Chen CJ, Hildesheim A. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan. J Infect Dis. 2021 Feb.223(3):441-444. Pubmedid: 32614957. Pmcid: PMC7982447.
    • Dickey BL, Coghill AE, Ellsworth GB, Wilkin TJ, Villa L, Giuliano AR. An Updated Systematic Review of Human Papillomavirus Genotype Distribution by Cervical Disease Grade in Women Living With Human Immunodeficiency Virus Highlights Limited Findings From Latin America. Sex Transm Dis. 2021 Dec.48(12):e248-e254. Pubmedid: 34110738. Pmcid: PMC8525704.
    • Liu Z, Sarathkumara YD, Chan JKC, Kwong YL, Lam TH, Ip DKM, Chiu BC, Xu J, Su YC, Proietti C, Cooper MM, Yu KJ, Bassig B, Liang R, Hu W, Ji BT, Coghill AE, Pfeiffer RM, Hildesheim A, Rothman N, Doolan DL, Lan Q. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep. 2021 Dec.11(1):23664. Pubmedid: 34880297. Pmcid: PMC8655014.
    • Fuzzell LN, Vadaparampil ST, Giuliano AR, Liu Y, Coghill AE. Patterns of HIV Self-Disclosure in the Oncology Setting. JNCI Cancer Spectr. 2021 Aug.5(4). Pubmedid: 34350380. Pmcid: PMC8328009.
    • Logue JM, Zucchetti E, Bachmeier CA, Krivenko GS, Larson V, Ninh D, Grillo G, Cao B, Kim J, Chavez JC, Baluch A, Khimani F, Lazaryan A, Nishihori T, Liu HD, Pinilla-Ibarz J, Shah BD, Faramand R, Coghill AE, Davila ML, Dholaria BR, Jain MD, Locke FL. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2021 Apr.106(4):978-986. Pubmedid: 32327504. Pmcid: PMC8017820.
    • Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clin Cancer Res. 2020 Jul.26(13):3496. Pubmedid: 32611629.
    • Coghill AE, Proietti C, Liu Z, Krause L, Bethony J, Prokunina-Olsson L, Obajemu A, Nkrumah F, Biggar RJ, Bhatia K, Hildesheim A, Doolan DL, Mbulaiteye SM. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma. Cancer Epidemiol Biomarkers Prev. 2020 Jan.29(1):57-62. Pubmedid: 31619404. Pmcid: PMC6954331.
    • Corrigan KL, Nogueira L, Yabroff KR, Lin CC, Han X, Chino JP, Coghill AE, Shiels M, Jemal A, Suneja G. The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States. Cancer. 2020 Feb.126(3):559-566. Pubmedid: 31709523. Pmcid: PMC6980281.
    • Liu Z, Jarrett RF, Hjalgrim H, Proietti C, Chang ET, Smedby KE, Yu KJ, Lake A, Troy S, McAulay KA, Pfeiffer RM, Adami HO, Glimelius B, Melbye M, Hildesheim A, Doolan D, Coghill AE. Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma. Int J Cancer. 2020 Aug.147(3):608-618. Pubmedid: 31618442.
    • Simon J, Liu Z, Brenner N, Yu KJ, Hsu WL, Wang CP, Chien YC, Coghill AE, Chen CJ, Butt J, Proietti C, Doolan DL, Hildesheim A, Waterboer T. Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology. J Clin Microbiol. 2020 Apr.58(5). Pubmedid: 32102852. Pmcid: PMC7180240.
    • Coghill AE, Bellizzi AM, Lynch CF, Shiels MS, Selk FR, Gillison M, Hernandez BY, Chan OTM, Engels EA. Pathology Characterization and Detection of Human Papillomavirus Type 16 in Rectal Squamous Cell Carcinomas. Clin Gastroenterol H. 2019 Sep.17(10):2129-2131. Pubmedid: 30448596. Pmcid: PMC6520215.
    • Coghill AE, Suneja G, Rositch AF, Shiels MS, Engels EA. HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United States. JAMA Oncol. 2019 Sep.5(9):e191742. Pubmedid: 31369037. Pmcid: PMC6681563.
    • Liu Z, Yu KJ, Coghill AE, Brenner N, Cao SM, Chen CJ, Chen Y, Doolan DL, Hsu WL, Labo N, Middeldorp JM, Miley W, Simon J, Wang CP, Waterboer T, Whitby D, Xie SH, Ye W, Hildesheim A. Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization. J Clin Microbiol. 2019 Oct.57(11). Pubmedid: 31434722. Pmcid: PMC6813000.
    • D'Arcy ME, Coghill AE, Lynch CF, Koch LA, Li J, Pawlish KS, Morris CR, Rao C, Engels EA. Survival after a cancer diagnosis among solid organ transplant recipients in the United States. Cancer. 2019 Mar.125(6):933-942. Pubmedid: 30624768. Pmcid: PMC6403005.
    • Yu G, Hsu WL, Coghill AE, Yu KJ, Wang CP, Lou PJ, Liu Z, Jones K, Vogt A, Wang M, Mbulaiteye SM, Chen HH, Boland J, Yeager M, Diehl SR, Chen CJ, Hildesheim A, Goldstein AM. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma. Sci Rep. 2019 Jul.9(1):9916. Pubmedid: 31289279. Pmcid: PMC6617453.
    • Coghill AE, Han X, Suneja G, Lin CC, Jemal A, Shiels MS. Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base. Cancer. 2019 Aug.125(16):2868-2876. Pubmedid: 31050361. Pmcid: PMC6663596.
    • Coghill AE, Engels EA, Schymura MJ, Mahale P, Shiels MS. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States. J Natl Cancer Inst. 2018 Sep.110(9):959-966. Pubmedid: 29529223. Pmcid: PMC6136931.
    • Menon MP, Coghill A, Mutyaba IO, Phipps WT, Okuku FM, Harlan JM, Orem J, Casper C. Association Between HIV Infection and Cancer Stage at Presentation at the Uganda Cancer Institute. J Glob Oncol. 2018 Sep.4:1-9. Pubmedid: 30241147. Pmcid: PMC6180750.
    • Coghill AE, Hsu WL, Yang Q, Wang CP, Lou PJ, Yu KJ, Yu G, Diehl SR, Chen CJ, Goldstein AM, Hildesheim A. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants. J Gen Virol. 2018 Sep.99(9):1268-1273. Pubmedid: 29975184. Pmcid: PMC6230770.
    • Rositch AF, Jiang S, Coghill AE, Suneja G, Engels EA. Disparities and Determinants of Cancer Treatment in Elderly Americans Living With Human Immunodeficiency Virus/AIDS. Clin Infect Dis. 2018 Nov.67(12):1904-1911. Pubmedid: 29718138. Pmcid: PMC6260168.
    • Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A. Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome. J Infect Dis. 2018 May.217(12):1923-1931. Pubmedid: 29509907. Pmcid: PMC6279144.
    • Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clin Cancer Res. 2018 Mar.24(6):1305-1314. Pubmedid: 29301829. Pmcid: PMC5856605.
    • Mahale P, Engels EA, Coghill AE, Kahn AR, Shiels MS. Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States. Clin Infect Dis. 2018 Jun.67(1):50-57. Pubmedid: 29325033. Pmcid: PMC6248478.
    • Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma. J Med Virol. 2018 Jan.90(1):191-195. Pubmedid: 28833336.
    • Menon M, Coghill A, Mutyaba I, Okuku F, Phipps W, Harlan J, Orem J, Casper C. Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute. PLoS One. 2018 Feb.13(2):e0191967. Pubmedid: 29389998. Pmcid: PMC5794100.
    • Coghill AE, Schenk JM, Mahkoul Z, Orem J, Phipps W, Casper C. Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda. Aids. 2018 Feb.32(4):505-512. Pubmedid: 29381560. Pmcid: PMC5872837.
    • Coghill AE, Bu W, Hsu WL, Nguyen H, Yu KJ, Chien YC, Chen CJ, Cohen JI, Hildesheim A. Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk. J Infect Dis. 2018 Aug.218(6):886-891. Pubmedid: 29718378. Pmcid: PMC6093398.
    • Coghill AE, Strickler HD. Survival Deficit for HIV-Infected Lymphoma Patients in the National Cancer Database. Cancer Epidemiol Biomarkers Prev. 2017 Mar.26(3):289-290. Pubmedid: 28254955. Pmcid: PMC5340270.
    • Coghill AE, Pfeiffer RM, Shiels MS, Engels EA. Excess Mortality among HIV-Infected Individuals with Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017 Jul.26(7):1027-1033. Pubmedid: 28619832. Pmcid: PMC5500417.
    • Suneja G, Coghill A. Cancer care disparities in people with HIV in the United States. Curr Opin HIV AIDS. 2017 Jan.12(1):63-68. Pubmedid: 27753654. Pmcid: PMC6424354.
    • Ferreira MP, Coghill AE, Chaves CB, Bergmann A, Thuler LC, Soares EA, Pfeiffer RM, Engels EA, Soares MA. Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer. Aids. 2017 Feb.31(4):523-531. Pubmedid: 28060014. Pmcid: PMC5263104.
    • Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States. J Clin Oncol. 2016 Sep.34(27):3276-3283. Pubmedid: 27507879. Pmcid: PMC5024548.
    • Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clin Cancer Res. 2016 Jul.22(14):3451-3457. Pubmedid: 26920891. Pmcid: PMC4947430.
    • Coghill AE, Shiels MS, Rycroft RK, Copeland G, Finch JL, Hakenewerth AM, Pawlish KS, Engels EA. Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?. Aids. 2016 Jan.30(1):105-112. Pubmedid: 26372482. Pmcid: PMC4703472.
    • Coghill AE, Shiels MS, Suneja G, Engels EA. Reply to L. Dal Maso et al. J Clin Oncol. 2016 Feb.34(4):390-391. Pubmedid: 26598741.
    • Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM. Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. Am J Transplant. 2016 Feb.16(2):565-573. Pubmedid: 26824445. Pmcid: PMC5500236.
    • Liu Z, Coghill AE, Pfeiffer RM, Hsu WL, Lou PJ, Wang CP, Yu KJ, Niwa S, Brotzman M, Ye W, Chen CJ, Hildesheim A. Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan. Int J Cancer. 2016 Dec.139(11):2467-2473. Pubmedid: 27537611.
    • Pyakurel R, Sharma N, Paudel D, Coghill A, Sinden L, Bost L, Larkin M, Burrus CJ, Roy K. Cause of Death in Women of Reproductive Age in Rural Nepal Obtained Through Community-Based Surveillance: Is Reducing Maternal Mortality the Right Priority for Women's Health Programs?. Health Care Women Int. 2015 Oct.36(6):655-662. Pubmedid: 24690028.
    • Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiol Biomarkers Prev. 2015 Oct.24(10):1548-1556. Pubmedid: 26224796. Pmcid: PMC4592448.
    • Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol. 2015 Jul.33(21):2376-2383. Pubmedid: 26077242. Pmcid: PMC4500831.
    • Coghill AE, Engels EA. Are cancer outcomes worse in the presence of HIV infection?. Cancer Epidemiol Biomarkers Prev. 2015 Aug.24(8):1165-1166. Pubmedid: 26240170. Pmcid: PMC4527081.
    • Coghill AE, Hildesheim A. Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. Am J Epidemiol. 2014 Oct.180(7):687-695. Pubmedid: 25167864. Pmcid: PMC4271109.
    • Coghill AE, Hsu WL, Pfeiffer RM, Juwana H, Yu KJ, Lou PJ, Wang CP, Chen JY, Chen CJ, Middeldorp JM, Hildesheim A. Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan. Cancer Epidemiol Biomarkers Prev. 2014 Jul.23(7):1213-1219. Pubmedid: 24769890. Pmcid: PMC4082438.
    • Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW. Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Gene Chromosome Canc. 2014 Jul.53(7):568-578. Pubmedid: 24677636. Pmcid: PMC4326223.
    • Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C. Contribution of HIV infection to mortality among cancer patients in Uganda. Aids. 2013 Nov.27(18):2933-2942. Pubmedid: 23921614. Pmcid: PMC4319357.
    • Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA. Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res. 2013 Jan.73(2):767-775. Pubmedid: 23149914. Pmcid: PMC3588850.
    • Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM. Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study. Pharmacogenet Genomics. 2013 Aug.23(8):428-437. Pubmedid: 23778325. Pmcid: PMC4435676.
    • Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2012 Oct.21(10):1792-1798. Pubmedid: 22899730. Pmcid: PMC3467328.
    • Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, LaCroix A, Newcomb PA. The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2012 Nov.21(11):1966-1973. Pubmedid: 22933426. Pmcid: PMC3493711.
    • Newcomb PA, Savu A, Phipps AI, Coghill AE, Yasui Y. Impact of colon cancer screening on family history phenotype. Epidemiology. 2012 Mar.23(2):308-310. Pubmedid: 22252410. Pmcid: PMC3299289.
    • Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM. Genetic variation in inflammatory pathways is related to colorectal cancer survival. Clin Cancer Res. 2011 Nov.17(22):7139-7147. Pubmedid: 21976545. Pmcid: PMC3218294.
    • Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA. Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women. Gene Chromosome Canc. 2011 Nov.50(11):875-886. Pubmedid: 21910156. Pmcid: PMC3201720.
    • Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Brit J Cancer. 2011 Mar.104(5):763-768. Pubmedid: 21304527. Pmcid: PMC3048198.
    • Coghill AE, Hansen S, Littman AJ. Risk factors for eclampsia: a population-based study in Washington State, 1987-2007. Am J Obstet Gynecol. 2011 Dec.205(6):553.e1-553.e7. Pubmedid: 21855842.
    • Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut. 2011 Apr.60(4):491-498. Pubmedid: 21051449. Pmcid: PMC3049822.
    • Coghill AE, Newcomb PA, Potter JD. Aspirin use, colorectal cancer survival, and loss to follow-up. Jama. 2009 Dec.302(23):2549. Pubmedid: 20009049.
  • Grants

    • Title: The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
      Sponsor: Nat Institutes of Health
      PI (MPI): Coghill, A.
    • Title: Establishing a Multi-site HIV Oncology Research Program in Florida
      Sponsor: Moffitt Cancer Center
      PI: Coghill, A.
    • Title: HIV Genomic Aging Project in Oncology (HIV-GAP)
      Sponsor: Nat Institutes of Health
      PI (Contact): Coghill, A., PI (MPI): Johnson, N.
    • Title: The role of Accelerated Biological Aging in HIV control and Non-AIDS-defining Cancer Risk (Biospecimens/Biocohort)
      Sponsor: Nat Institutes of Health
      PI: Cleveland, J., Project PI: Coghill, A.
    • Title: AIDS Malignancy Consortium (AMC)
      Sponsor: Nat Institutes of Health
      PI: Coghill, A.

Find a Researcher Search